Kymera Therapeutics Inc (KYMR) — Free Cash Flow Generation Index
Kymera Therapeutics Inc (KYMR) has a Free Cash Flow Generation Index of -0.44x as of December 2023. Free cash flow of $-3.58 Million represents 0% of operating cash flow ($8.04 Million). Explore Kymera Therapeutics Inc (KYMR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Kymera Therapeutics Inc Free Cash Flow Generation Index (2019–2020)
Historical FCF Generation Index trend for Kymera Therapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see Kymera Therapeutics Inc (KYMR) cash conversion ratio.
Annual Free Cash Flow Generation for Kymera Therapeutics Inc (2019–2020)
Year-by-year Free Cash Flow Generation Index for Kymera Therapeutics Inc. Check Kymera Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.90x | $79.03 Million | $88.13 Million | $9.10 Million | ▼ -7.6% |
| 2019 | 0.97x | $17.37 Million | $17.91 Million | $532.00K | — |